Conclusion
The results show that preoperative intravenous tranexamic acid reduces the total blood loss irrespective of the route of hysterectomy and the number of perioperative transfusions. No incidences of serious adverse events occurred. Thus, tranexamic acid should be considered as a prophylactic treatment before benign hysterectomy.
Keywords:Anti-fibrinolytic therapy, Benign hysterectomy, Bleeding complication, Hysterectomy, Tranexamic acid